Regeneron Sanofi Release Confirms Approval Of Praluent By: Benzinga via Benzinga July 24, 2015 at 15:19 PM EDT Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) approved ... Read More >> Related Stocks: Regeneron Pharmaceuticals